MS affects brain cells. In contrast to cells of other organs, brain cells are not in close contact with blood, and nutrients or immune cells that are prevalent in blood…read more
While several studies have shown that many people with MS are overweight, the impacts on the disease of having a high body mass index are not well studied in MS.read more
A drug currently used to treat epilepsy could be used to protect cells in the optic nerve for people with all types of MS.read more
Stem cells are considered by many to hold the ultimate promise for repair and cure for a variety of chronic and degenerative conditions. While great progress is being made in…read more
New research published last week has shown that consuming large amounts of coffee decreases the risk of developing MS.read more
Heat sensitivity in people with MS is well documented, however the underlying physiological mechanisms are still unclear.read more
Stem Cell research is currently front of mind for the media and many people with MS. MS Translate recently interviewed Dr Violaine Harris from the Tisch MS Research Centre in…read more
Genentech, a member of the Roche Group, announced in a February 16 press release that the experimental therapy ocrelizumab has been granted ‘Breakthrough Therapy designation’ by the US Food and…read more
An article published recently in the journal PLOS One led by Western Australian researchers Dr Monica Tschochner and Dr David Nolan from Murdoch University in Perth, has found new evidence…read more
Kiss Goodbye to MS has launched around the world. This is a crucial moment for MS as the world unites to increase the funding available for MS research globally.read more
The current supply of neurologists in New Zealand is 36 full-time equivalents (FTE), insufficient to meet current demand of 74 FTE. Demand will grow over time and if status quo…read more
Following our earlier report in 2014 of disappointing preliminary results from a phase III clinical trial of Gilenya (fingolimod) in people with primary progressive MS (PPMS), the full results of…read more
Mental health issues are common in people with MS, and in particular can have a significant impact in the period immediately following diagnosis.read more
Many observational studies have provided evidence that low levels of vitamin D in the blood are associated with an increased risk of developing MS and are also associated with more…read more
Researchers from the UK have this week published results suggesting that a medication used to treat epilepsy may hold promise for preventing nerve damage and slowing the accumulation of disability…read more
Ocrelizumab, an experimental new treatment option for MS, has had promising results in recent Phase III clinical trials for both primary progressive MS and relapsing remitting MS.read more
JDRF Australia is the national funding body for research into type 1 diabetes, an autoimmune disease which has much in common with MS.read more
The 2015 Progress in MS Research Conference, held recently in Melbourne, was a resounding success with researchers and clinicians from all over Australia coming together to discuss results and ideas.read more
In March this year we wrote about Dr Cheryl Li, an early career researcher from the University of Sydney who received the Ian Ballard Travel Award, to collaborate and learn…read more
A clinical trial of sex hormone estriol (oestrogen) supplementation in women with MS has not found a definitive benefit for reducing MS inflammatory activity or preventing relapses.read more
